Does Pecs II Block Reduce the Incidence of Post Mastectomy Pain Syndrome (PMPS)? A Cross Sectional Study
PMPS
2 other identifiers
observational
288
1 country
1
Brief Summary
Post mastectomy pain syndrome (PMPS) is a chronic pain condition that develops after breast cancer surgery. The objective of this study was to determine if Pecs II block administered prior to general anesthesia (GA) reduced the incidence of PMPS after mastectomy and axillary clearance (MAC) when compared with conventional analgesic therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2019
CompletedFirst Submitted
Initial submission to the registry
September 17, 2019
CompletedFirst Posted
Study publicly available on registry
September 19, 2019
CompletedSeptember 19, 2019
September 1, 2019
10 months
September 17, 2019
September 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of PMPS
Incidence of Post mastectomy pain syndrome (PMPS)
2 years
Secondary Outcomes (1)
Severity of PMPS
2 years
Study Arms (2)
conventional analgesic therapy
Patient underwent mastectomy with conventional analgesic therapy
Pecs II block
Patient underwent mastectomy with conventional analgesic therapy with pre induction Pecs II block
Interventions
Peripheral nerve block - Regional anesthesia : Pectoral Nerve block type 2
Eligibility Criteria
patient underwent unilateral mastectomy for breast carcinoma
You may qualify if:
- patient underwent unilateral mastectomy for breast carcinoma
You may not qualify if:
- past history of chronic pain and on regular analgesics, chemotherapy or radiotherapy before surgery, surgical complications (such as infection or wound breakdown) or cancer recurrence, history of psychiatric illness, inability to be contacted, inability or unwillingness to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universiti Kebangsaan Malaysia Medical Center
Cheras, Kuala Lumpur, 56000, Malaysia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
YEOH CHIH NIE, Mmed
Universiti Kebangsaan Malaysia Medical Centre
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2019
First Posted
September 19, 2019
Study Start
March 6, 2018
Primary Completion
December 28, 2018
Study Completion
February 20, 2019
Last Updated
September 19, 2019
Record last verified: 2019-09